DividendChannel.com
PCRX December 2025 Options Begin Trading
Dividend Channel Staff - Thursday, May 9, 11:02 AM

Read More »


Commit To Buy Pacira BioSciences At $17.50, Earn 10.4% Annualized Using Options
Dividend Channel Staff - Wednesday, April 24, 12:02 PM

Read More »


Noteworthy Tuesday Option Activity: PCRX, CMG, CVNA
Dividend Channel Staff - Tuesday, April 23, 3:18 PM

Read More »


Oversold Conditions For Pacira BioSciences (PCRX)
Dividend Channel Staff - Monday, April 15, 11:59 AM

Read More »


Commit To Purchase Pacira BioSciences At $15, Earn 12.5% Annualized Using Options
Dividend Channel Staff - Thursday, April 4, 11:33 AM

Read More »


Analysts Expect IJR Will Reach $120
Dividend Channel Staff - Thursday, March 14, 7:15 AM

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Core S&P Small-Cap ETF (IJR), we found that the implied analyst target price for the ETF based upon its underlying holdings is $120.18 per unit. Read More »


Analysts Predict 50% Gains Ahead For The Holdings of QQQS
Dividend Channel Staff - Monday, February 12, 10:54 AM

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco NASDAQ Future Gen 200 ETF (QQQS), we found that the implied analyst target price for the ETF based upon its underlying holdings is $39.94 per unit. Read More »


RSI Alert: Pacira BioSciences (PCRX) Now Oversold
Dividend Channel Staff - Thursday, February 8, 12:23 PM

Read More »


The Implied Analyst 12-Month Target For MMSC
Dividend Channel Staff - Thursday, January 11, 6:01 AM

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Multi-Manager Small Cap Opportunities ETF (MMSC), we found that the implied analyst target price for the ETF based upon its underlying holdings is $18.76 per unit. Read More »


Notable Wednesday Option Activity: PLCE, PCRX, SYY
Dividend Channel Staff - Wednesday, January 3, 3:23 PM

Read More »


Oversold Conditions For Pacira BioSciences (PCRX)
Dividend Channel Staff - Friday, October 27, 3:31 PM

Read More »


Peek Under The Hood: VIOO Has 27% Upside
Dividend Channel Staff - Thursday, October 5, 7:05 AM

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard S&P Small-Cap 600 ETF (VIOO), we found that the implied analyst target price for the ETF based upon its underlying holdings is $108.29 per unit. Read More »


Notable Tuesday Option Activity: MASI, AMR, PCRX
Dividend Channel Staff - Tuesday, October 3, 3:26 PM

Read More »


Commit To Buy Pacira BioSciences At $25, Earn 5% Using Options
Dividend Channel Staff - Wednesday, September 13, 1:52 PM

Read More »


Relative Strength Alert For Pacira BioSciences
Dividend Channel Staff - Tuesday, September 12, 11:44 AM

Read More »


Notable Monday Option Activity: BMBL, NVAX, PCRX
Dividend Channel Staff - Monday, August 21, 4:23 PM

Read More »


The Implied Analyst 12-Month Target For RZG
Dividend Channel Staff - Monday, July 3, 8:20 AM

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco S&P SmallCap 600— Pure Growth ETF (RZG), we found that the implied analyst target price for the ETF based upon its underlying holdings is $153.21 per unit. Read More »


Pacira BioSciences is Now Oversold (PCRX)
Dividend Channel Staff - Wednesday, June 7, 4:03 PM

Read More »


Implied RZG Analyst Target Price: $152
Dividend Channel Staff - Thursday, June 1, 8:00 AM

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco S&P SmallCap 600— Pure Growth ETF (RZG), we found that the implied analyst target price for the ETF based upon its underlying holdings is $151.65 per unit. Read More »


Monday's ETF with Unusual Volume: PJP
Dividend Channel Staff - Monday, February 10, 12:17 PM

Read More »


Wednesday's ETF with Unusual Volume: XPH
Dividend Channel Staff - Wednesday, October 24, 1:33 PM

The SPDR S&P Pharmaceuticals ETF (XPH) is seeing unusually high volume in afternoon trading Wednesday, with over 529,000 shares traded versus three month average volume of about 109,000. Shares of XPH were down about 1.6% on the day. Read More »


Wednesday Sector Laggards: Biotechnology, Drugs
Dividend Channel Staff - Wednesday, September 21, 2:10 PM

In trading on Wednesday, biotechnology shares were relative laggards, down on the day by about 1.3%. Helping drag down the group were shares of Mast Therapeutics (MSTX), down about 80.6% and shares of Northwest Biotherapeutics (NWBO) down about 14.7% on the day. Read More »


Thursday's ETF Movers: GDX, XPH
Dividend Channel Staff - Thursday, September 24, 3:11 PM

In trading on Thursday, the Gold Miners ETF (GDX) is outperforming other ETFs, up about 6.3% on the day. Components of that ETF showing particular strength include shares of Agnico Eagle Mines (AEM), up about 11.1% and shares of Eldorado Gold (EGO), up about 9.7% on the day. Read More »


Tuesday 9/15 Insider Buying Report: NEP, PCRX
Dividend Channel Staff - Tuesday, September 15, 10:44 AM

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys. Read More »


Older articles »

Quotes delayed 20 minutes
  • A Brief Dividend History
  • Top Dividends
  • Opting for the Cash Dividend
  • What is a Dividend?
  • Dividend Calculator
  • Dividend Yield Traps to Avoid
  • Dividend Paying Stocks
  • High Yield Stocks Paying Monthly
  • Dividend Stocks: Their Importance
  • Dividend ETFs
  • High Dividend Stocks Paying Quarterly
  • Dividend Aristocrats List
  • Top Dividend Stocks YTD


  • Other news: News from PR Newswire
Warren Buffett Dividend Stocks
Best Dividend Stocks 2004-2024
Dividend Growth Stocks: 25 Aristocrats
Future Dividend Aristocrats: Close Contenders
The Top 10 DividendRank'ed Stocks
Decades of Increasing Payments: 25 S.A.F.E. Dividend Stocks
Best High Dividend Stocks 2004-2024
The DividendRank Top 25
The Top 10 DividendRank'ed DJIA Components
Feel-Good Income: 25 Socially Responsible Dividend Stocks
Top Dividend Stocks 2014-2024
The Top 10 DividendRank'ed Dow Transports Components
The Top 10 DividendRank'ed Dow Utilities Components
The Top 10 DividendRank'ed Nasdaq 100 Components
Best High Yield Stocks 2014-2024
10 Stocks Going Ex-Dividend
10 Oversold Dividend Stocks
10 High Yield Baby Bonds
10 Stocks Where Yields Got More Juicy
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Top Ranked Dividend Stocks With Insider Buying
Top Dividend Stocks 2019-2024
Best Dividend Stocks Analysts Like in the S&P
Best Dividend Paying Stocks Analysts Like in the Dow
10 Cheap Dividend Stocks Under $10
10 Low Priced Dividend Stocks Under $5
Top High Dividend Yield Stocks 2019-2024
Broker Darlings: Top 15 Analyst Picks of the Dow
Top 25 Broker Analyst Picks of the S&P 500
Forgotten S&P 500 Giants: Analysts' Current Least Favorites
10 ETFs With Stocks That Insiders Are Buying
25 Dividend Giants Widely Held By ETFs
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
Cheap Energy Stocks Paying Dividends
Cheap Oil Stocks Paying Dividends
10 Metals Stocks You Can Buy Cheaper Than Insiders Did
10 Oversold Metals Stocks
10 Must-Know High-Yield REITs
10 Top DividendRank'ed Financials
10 Top DividendRank'ed Metals Stocks
10 Oversold Energy Stocks
10 Top DividendRank'ed Energy Stocks
10 Top DividendRank'ed Utility Stocks
10 Stocks Crossing Below Book Value
10 Stocks Crossing Above Their 200 Day Moving Average
10 Stocks Crossing Below Their 200 Day Moving Average
10 Dividend Stocks Crossing Above Their 200 DMA
10 Dividend Stocks Crossing Below Their 200 DMA
10 Top Covered Call ETFs
The 10 Biggest ETFs
The 10 Best ETF Performers
The 10 Worst ETF Performers
10 ETFs With Notable Inflows
10 ETFs With Notable Outflows
Top 10 Analyst Rated Consumer Stocks
Top 10 Analyst Rated Dividend Stocks
Top 10 Analyst Rated Energy Stocks
Warren Buffett Energy Stocks
Top 10 Analyst Rated Financial Stocks
Warren Buffett Bank Stocks
Top 10 Analyst Rated Healthcare Stocks
Top 10 Analyst Rated REIT Stocks
Top 10 Analyst Rated Technology Stocks
Warren Buffett Technology Stocks
The Top 10 DividendRank'ed Canadian Stocks
The DividendRank Canada Top 25
10 Canadian Stocks Going Ex-Dividend
10 Oversold Canadian Stocks
10 Canadian Stocks Where Yields Got More Juicy
10 Must-Know High-Yield Canadian Real Estate Stocks
10 Top DividendRank'ed Canadian Financials
10 Must-Know High-Yield Canadian Energy Stocks
10 Canadian Stocks Crossing Below Book Value
10 Canadian Stocks Crossing Above Their 200 Day Moving Avg
10 Canadian Stocks Crossing Below Their 200 Day Moving Avg
Stock market game

Dividend Articles | Dividend Channel | www.DividendChannel.com

Copyright © 2010 - 2024, All Rights Reserved Nothing in Dividend Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and dividend videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Dividend Channel; Meet Our Editorial Staff.